Replies to post #6314 on Biotech Values

[AlohaDan]

Re: SNMX

Here's a post from the Motley Fool by wpdolan.

I'll try to do some board swapping msgs so info can be shared by subscribers to each.

I'd agree on the fundamentals, and I'd also vouch for the Advisory Board and scientists on track. I have friends working for two of the founders (Zuker and Tsien) -- both labs are ridiculously productive and innovative. Zuker continues to lead the field in identifying and cloning taste receptors, and I can't think of someone better to lead an effort in taste receptor technologies. Furthermore, their contracted access to a 500,000 compound library from Aurora (now part of Invitrogen) gives them another edge.

I'm interested in learning more details on the royalties arrangements -- the NBT article (accessible at http://www.nature.com/cgi-taf/DynaPage.taf?file=/nbt/journal/v22/n10/full/nbt1004-1203.html for those with a subscription) cited a 1-4% royalty rate, but I'd like to see more financial details.